ClomiPHENE Citrate Tablets 50 mg Recalled Due to Temperature Abuse
McKesson Medical-Surgical is recalling ClomiPHENE Citrate Tablets 50 mg due to temperature abuse during distribution. The medication was distributed nationwide; patients should contact their healthcare provider for guidance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves cGMP deviations related to temperature abuse, a manufacturing and handling process deviation. No illnesses or injuries have been reported in the source material. Per the severity rubric, recalls without reported incidents where the hazard is theoretical are rated at most 3 (High).
Plain-English summary
McKesson Medical-Surgical Inc. is recalling ClomiPHENE Citrate Tablets, USP 50 mg (NDC 49884-701-55), 30-count bottles manufactured by PAR Pharma. The recall affects 240 cartons, each containing 3 blister packs. The recall was initiated due to cGMP deviations involving temperature abuse during distribution.
The recalled product was distributed nationwide to healthcare facilities and pharmacies. McKesson Medical-Surgical is unable to identify the specific lot numbers associated with individual consignees; each customer notification letter specifies the dates the product may have been shipped to that facility.
Patients who have this medication should contact their healthcare provider or pharmacy if they believe they may have received recalled product. Healthcare providers and pharmacies should quarantine any remaining affected product and follow the instructions provided in their recall notification from McKesson Medical-Surgical.
This Class II recall is being overseen by the U.S. Food and Drug Administration.
The recalled product
- Product
- ClomiPHENE Citrate Tablets, USP 50 mg, 30-count bottle, Rx only, MFG: PAR Pharma, NDC 49884-701-55
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug
- Hazard
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18